Use LEFT and RIGHT arrow keys to navigate between flashcards;
Use UP and DOWN arrow keys to flip the card;
H to show hint;
A reads text to speech;
128 Cards in this Set
- Front
- Back
Depression CAN include:
|
psychotic symptoms
|
|
7 signs of Mania:
|
DIG FAST P
Distractibility Irresponsibility Grandiosity Flight of thought Activity Sleep (dec) Talk (pressured speech) Psychosis |
|
5 primary mood disorders:
|
1. MDD
2. Bipolar Type 1 3. Bipolar Type 2 4. dysthymic disorder 5. cyclothymic disorder |
|
diagnosis of MDD requires 5 of these 9 criteria in a span of 2 weeks:
|
SAG E CAPS D
Sleep disturbance Anhedonia Guilt Energy loss/fatigue Concentration probs Appetite/wt loss (5% of body weight) Psychomotor retardation SI Depressed mood |
|
dysthymia = less-severe MDD =
|
low self-esteem and decreased productivity,
WITHOUT extreme symps like anhedonia and suicidality - has to last 2 years to be diagnosed as such |
|
hypomania =
|
mild symptoms of mania like increased sexual interest and talkativeness,
- lasts at least **4 days** |
|
anhedonia =
|
absence of pleasure in one's usual activities
|
|
SWAG symptoms to differentiate depression from sadness:
|
S—Suicidality (serious thoughts or attempts at self-destruction) or
W—Weight loss (more than 5% of normal body weight without medical cause) or A—Anhedonia (loss of pleasure or interest in usually pleasurable activities) or G—Guilt (feelings of responsibility for negative life events when little or none exists) |
|
Major Depressive Disorder (MDD) =
|
Unhappiness, decreased interest in one's usual activities and decreased appetite for pleasurable stimuli such as sex and food
|
|
Bipolar Disorder Type I =
|
discrete episodes of both depression and mania
|
|
Bipolar Disorder Type II =
|
discrete episodes of both depression and hypomania
|
|
Cyclothymic Disorder =
|
alternating states of both dysthymia and hypomania
- (like dysthymia, must persist for 2 yrs in adults in order to be diagnosed) |
|
Mood Disorder Resulting from General Medical Condition =
|
*secondary mood disorder,* resulting from illness or treatment of illness
mood symptoms in a medically ill patient **resulting directly from the illness or its treatment** rather than from a primary mood disorder |
|
Substance-Induced Mood Disorder =
|
mood symptoms caused or exacerbated by the use OR withdrawal of drugs/meds
|
|
Atypical Depression ~~
(4) |
1. weight GAIN rather than loss,
2. excessive somnolence 3. feelings of heaviness in the arms and legs (leaden paralysis) 4. craving for carbohydrate-rich food |
|
in Masked Depression, pts are:
|
unaware of or deny that they have MDD;
~~ ***vague physical symptoms*** |
|
Seasonal Affective Disorder = type of MDD; commonly presents with:
|
ATYPICAL symptoms
=> light +/- antidepressants |
|
pressured speech =
|
speech that seems forced and rapid
|
|
flight of ideas =
|
thoughts move quickly from one to another
|
|
Adjustment Disorder:
(3) |
1. mood symptoms DON'T meet the full criteria for a major depressive episode
2. occur within 3 mths of a significant psychosocial stressor (but it's not bereavement) 3. persist for up to 6 mths after the stressor has terminated |
|
ECT =
|
inducing a grand mal seizure to effectively treat severe depression
|
|
effect of Lithium:
|
stabilizes mood
|
|
SE's of Lithium:
(4) |
1. renal dysfunction
2. thyroid dysfunction 3. tremor 4. wt gain understand that lithium is very effective but it is also very toxic with a narrow therapeutic window a. Common: cognitive slowing, GI upset, polyuria/polydipsia, tremor b. Severe: cardiac conduction delays, diabetes insipidus, hypothyroidism c. Moderate toxicity: i. Symptoms – twitching, slurred speech, lethargy, hyperreflexia, vertigo, GI upset ii. Treatment – supportive measures (stop lithium, fluids, etc.) d. Severe toxicity: i. Symptoms – seizures, stupor, coma, CV collapse, death ii. Treatment – hemodialysis |
|
when Li is contraindicated or when the patient shows rapid-cycling bipolar disorder (>4 episodes in a year), _________________________________ are preferred
|
anticonvulsants like CBZ
- combinations of Li and anticonvulsants can be used for patients who do not show an adequate response to either |
|
sedative agents such as Lorazepam and Clonazepam are commonly used in the emergency room to treat:
|
acute manic states,
b/c they resolve symps quickly |
|
Sometimes, depressed patients show confused thinking and mild memory problems. In the elderly, these cognitive symptoms may be misdiagnosed as dementia, that is,
|
pseudodementia
|
|
which class of meds can provoke either hypomania or full-blown mania in a Bipolar pts?
|
antidepressants
|
|
major difference between Bipolar and cyclothymic disorder =
|
NO psychosis in cyclothymic disorder
|
|
2 MAOI antidepressants:
|
1. Phenel-zine
2. Tra-nyl-cypromine |
|
mechanism of MAOI's:
|
*irreversibly* inhibit MAO,
the enzyme that breaks down monoamine NT's |
|
3 indications for MAOI's:
|
1. first-line for ATYPICAL depression
2. anxiety 3. MDD (after other tx's have failed) |
|
SE's of MAOI's:
(3) |
orthostatic hypotension, sedation, sexual dysfunction
|
|
Interactions of MAOI's:
(2) |
1. risk of SER Syndrome if given in conjuction with SSRI's, SNRI's, etc.
Symptoms include diarrhea, restlessness, hyperreflexia, autonomic instability, hyperthermia, rigidity, and delirium. (Note the similarity to NMS; hyperreflexia is a distinguishing feature) 2. Tyramine-Induced Hypertensive Crisis: Tyramine is a potent releaser of NOR, which causes vasoconstriction and thus elevated BP. Tyramine is normally degraded by MAOa; when this enzyme is inhibited by MAOIs, small amounts of dietary tyramine can result in a hypertensive crisis. - Symptoms include nausea, vomiting, occipital headache, stiff neck, and sweating. - avoid foods high in tyramine (wine and cheese) |
|
6 SSRI antidepressants:
|
1. Ci-talo-pram
2. Es-ci-talo-pram 3. Fluoxetine 4. Fluvoxamine 5. Paroxetine 6. Sertraline |
|
mechanism of SSRIs:
|
blocks PREsynaptic reuptake of already-released SER
( => increased SER lvls) |
|
Indications for SSRI's:
(2) |
1. MDD
2. various anxiety disorders |
|
SE's of SSRI's:
(3) |
1. GI: nausea and loose bowel movements
2. sexual: decreased libido, delayed ejaculation, anorgasmia 3. wt gain (Paroxetine only) |
|
Interactions/met of SSRI's:
(4) |
1. H met
2. Fluoxetine has the longest h-life (~2 weeks) Fluvoxamine and Paroxetine have the shortest. - SSRIs with shorter half-lives are more likely to induce a discontinuation syndrome composed of flu-like symptoms and vivid dreams 3. all SSRIs are contraindicated with Pimozide (antipsychotic) 4. risk SER syndrome |
|
3 SNRI antidepressants:
|
1. Ven-la-faxine
2. Des-ven-la-faxine 3. Du-lox-etine |
|
mechanism of SNRIs:
|
block the reuptake of presynaptic SER and NOR
(Dose-dependent – at lower doses these drugs function as SSRIs; at higher doses they block the reuptake of NOR as well) |
|
Indications for SNRI's:
(3) |
1. MDD
2. various anxiety disorders 3. neuropathic pain |
|
SE's of SNRI's:
(3) |
1. GI
(nausea and loose bowel movements) 2. Sexual: decreased libido, delayed ejaculation, anorgasmia 3. HTN of diastolic BP |
|
Interactions/Metabolism of SNRI's:
(3) |
1. H met (CYP450)
2. Duloxetine = mod CYP450 inhibitor 3. risk SER Syndrome |
|
3 Tricyclic antidepressants:
|
1. Ami-triptyline
2. Nor-triptyline 3. I-mi-pramine |
|
mechanisms of Tricyclic Antidepressants (TCAs):
(3) |
1. block SER and NOR reuptake
2. block Histamine r's with high affinity 3. block Muscarinic r's with high affinity |
|
Indications for TCA's:
(4) |
1. MDD
2. chronic pain 3. HA's (prophylaxis and treatment) 4. enuresis (Imipramine only) |
|
SE's of TCA's:
(3) |
1. anticholinergic (blurred vision, constipation, dry mouth, orthostatic hypotension, sedation, urinary retention)
2. CV: tachycardia, prolonged QT 3. OD's lethal |
|
Interactions/met of TCA's:
(1) |
risk of SER Syndrome
|
|
4 Atypical Antidepressants:
|
1. Bupropion
2. Mir-ta-zapine 3. Amox-apine 4. Trazodone |
|
Bupropion =
|
atypical UNIcyclic antidepressant
|
|
mechanism of Bupropion (unicyclic antidepressant):
|
inhibits reuptake of ***DOPA and NOR***
- lack of sexual SE's = preferred over SSRI's |
|
indications for Bupropion:
(3) |
1. MDD
2. SAD 3. smoking cessation |
|
common SE's of Bupropion:
(5) |
1. constipation
2. HA 3, nausea 4. anxiety 5. insomnia |
|
severe SE's of Bupropion:
(2) |
1. sez's
(contraindicated in patients with eating disorders or epilepsy) 2. psychosis |
|
2 atypical antidepressant-tetracyclines:
|
1. Mirtazapine
2. Amoxapine |
|
mechanism of Mirtazapine and Amoxapine (tetracyclines):
|
increase concentrations of NOR and SER
|
|
Trazodone = Atypical Antidepressant =
|
**5HT2 antagonist**
=> prevents SER reuptake |
|
indications for Mirtazapine, Amoxapine, and Trazodone:
(2) |
1. MDD
2. insomnia (more sedating than other antidepressants) |
|
3 SE's of Mirtazapine and Amoxapine:
(tetracyclines) |
1. wt gain
2. sedation 3. agranulocytosis (severe, rare) |
|
SE's of Trazodone:
(2) |
1. anticholinergic (common)
2. priapism (urologic emergency) |
|
Interactions of Atypical Antidepressants:
(3) |
1. H met
2. avoid using with MAOIs (risk hypertensive crisis) 3. (Bupropion only) use with caution with other dopaminergic agents e.g. L-dopa (risk of DOPA toxicity) |
|
mechanism of Lithium:
|
alters cation transport across cell membranes in nerve/muscle cells
=> influences reuptake of SER +/- NOR |
|
interactions/metabolism of Li2+ :
(2) |
1. 100% renal
2. co-administration of diuretics, ACEI's, or NSAIDs (except salicylates) is dangerous due to risk of Li toxicity |
|
indications of Valproate:
(3) |
1. manic/maintenance phases of bipolar disorder
2. rapid-cycling pts and 3. mixed episodes (concurrent depressive and manic symptoms) |
|
indications for Carbamazepine:
(2) |
manic and maintenance phases of bipolar disorder
|
|
indications for Lamotrigine:
(2) |
maintenance and *depressive* episodes of bipolar
|
|
Valproate and carbamazepine are said to “treat from above” (during the manic/maintenance phases) while lamotrigine:
|
“treats from below” (during the maintenance/depressive phases).
|
|
mesolimbic dopaminergic tract =
|
the dopaminergic neurons in the ventral tegmentum of the BS.
which project forward to the frontal cortex, which releases DOPA to the nucleus accumbens |
|
nucleus accumbens (NA) =
|
a small nucleus in the BG associated with addiction
|
|
substance abuse =
|
substance use over minimum of **1 year** that leads to impairment of occupational, physical, or social functioning
- NOT diagnosed when the patient meets the criteria for substance dependence. |
|
substance dependence =
|
substance abuse + withdrawal symptoms, tolerance, or compulsive use
(so WORSE than substance abuse) |
|
withdrawal ~~
|
development of *physical OR psychological symps*
|
|
tolerance =
|
need for increased amounts to achieve the same effects
|
|
cross-tolerance =
|
development of tolerance to one substance because of using another substance
|
|
Benzodiazepines =
|
commonly-abused sedative psychoactives
- anxiolytics, hypnotics, and other indications |
|
Barbituates =
|
sedative psychoactives with high abuse potential
- rarely prescribed as hypnotics anymore |
|
prescription opioids =
|
m.c.ly abused class of prescription drugs
- abuse has been rising |
|
amphetamines =
(+2) |
commonly-abused stimulants
- prescribed for ADD and narcolepsy - stimulate the release of DOPA |
|
cocaine is a ___________ which blocks _______________________________
|
stimulant
the reuptake of DOPA |
|
detoxification =
|
treatment of withdrawal symptoms
|
|
flumazenil =
|
Benzo r' antagonist used in the treatment of Benzo OD
|
|
Naloxone =
|
opioid r' antagonist used in the treatment of opioid OD
|
|
disulfirim prevents alcohol use by:
|
blocking the breakdown of alcohol, resulting in acetaldehyde accumulation
|
|
concomitant ingestion of alcohol with disulfirim =>
(3) |
1. intense nausea
2. HA 3. flushing - all act as aversive stimuli |
|
Naltrexone =
|
an opioid r' antagonist for alcohol abuse
- works by blunting the positive effects of alcohol |
|
"MICA" patients =
|
mentally-ill chemically-addicted pts
= **both mental illness AND substance abuse** |
|
Buprenorphine =
|
mixed opioid agonist/antagonist
|
|
methamphetamines =
|
powerfully-addictive amphetamine derivatives
- known as "meth," "crystal" |
|
Amotivational Syndrome =
|
syndrome associated with *chronic marijuana use*, characterized by decreased desire to work and increased apathy
|
|
alcohol, Benzo's, and Barbs are:
ALL increase: |
sedatives
**all increase GABA** |
|
USD does NOT include:
|
LSD screen
|
|
one prominent symptom of Delirium =
|
fever
|
|
Longer than two months ~~
|
start thinking about depression (not bereavement anymore)
|
|
CAGE:
|
1. felt the need to CUT down?
2. Annoyed you by criticizing your drinking? 3. Guilty about drinking? 4. Eye-Opener? |
|
alcohol withdrawal treatment:
(3) |
1. *hospitalization*
(due to sez's, CV symps) 2. +Benzo's 3. +thiamine if DTs: fluid for dehydration, Lorazepam if liver-sick |
|
what do Naltrexone or acamprosate do in relation to alcohol?
|
blunt the positive effects of alcohol
|
|
heroin is an opioid; =>
|
mood elevation, dec. anxiety
|
|
classic triad of opioid OD =
|
1. coma
2. respiratory depression 3. miosis (pinpoint pupils) |
|
classic triad of opioid **withdrawal:**
|
1. piloerection (goose bumps)
2. lacrimation 3. rhinorrhea (autonomic instability) |
|
other symps of opioid withdrawal:
(4) |
1. Agitation
2. Sweating 3. Yawning 4. pupil dilation |
|
detox of opioids =
(2) |
1. Methadone or Buprenorphine for gradual withdrawal
2. Clonidine if abrupt withdrawal |
|
3 stimulants (drugs)
|
1. cocaine
2. amphetamines 3. nicotine |
|
stimulants cause increase in:
|
DOPA in the brain
=> elevation in mood, hallucinations/delusions |
|
drug for smoking cessation:
|
Bupropion
|
|
speedball =
|
stimulant + depressant
(e.g. cocaine + heroine) |
|
**high of cocaine is followed by:**
|
*depression,* sometimes within an hour
|
|
2 dangerous possibilities with cocaine use:
|
1. CV problems
2. sudden death |
|
withdrawal from stimulants =>
(think caffeine withdrawal) (3) |
1. tiredness
2. HA 3. hunger (if from amphetamines) |
|
treatment for stimulant use =
(2) |
1. Benzo's for agitation/anxiety
2. antipsychotics |
|
psilocybin =
|
"shrooms"
- hallucinogenic, no therapeutic indications |
|
monoamine increased by LSD:
(lysergic acid diethylamide) |
SER
- ingested |
|
mescaline =
|
hallucinogen derived from cactus
~~ Native Americans |
|
ketamine =
(+2) |
"special K"
- hallucinogenic anaesthesia - glutamate agonist |
|
MDMA =
(3-4-methylenedioxymethamphetamine) |
ecstasy
- a synthetic hallucinogen and amphetamine-like properties |
|
ecstasy can ALSO induce:
|
SER syndrome
|
|
hashish =
|
cannabis product
composed of resin glands |
|
THC =
(Tetrahydrocannabinol) |
principal psycho-active constituent (cannabinoid) of marijuana
|
|
cannibis =
|
marijuana
|
|
marijuana is a:
|
hallucinogen
|
|
6 symps of marijuana use:
|
1. inc. HR
2. inc. BP 3. red eyes 4. munchies 5. slowed rxn time 6. some hallucination |
|
PCP
(phencyclidine) (4) |
1. "angel dust"
2. hallucinogen 3. no therapeutic indications 4. glutaminergic |
|
PCP binds:
|
NMDA r's
|
|
symptoms of PCP uuse:
(3) |
1. inc. BP
2. agitation 3. violent episodes |
|
symptoms of PCP OD:
(4) |
1. hyperthermia
2. nystagmus 3. coma 4. death |
|
***there are NO specific treatments for:***
|
hallucinogen use/OD
|
|
pupil constriction ~~ which class of drugs?
|
opioids
|
|
pupil dilation ~~ which kinds of drugs?
(2) |
1. stimulants
2. LSD |
|
CV symps ~~ which kind of drugs?
(1) |
stimulants
|